Alkermes, Inc. (ALKS) Reports In-Line Q4 Loss of 14c; Guides FY12
Tweet
Share
E-mailGet Alerts ALKS Hot Sheet
Price: $48.33 +0.65%
Financial Fact:
INCOME TAX BENEFIT: -880K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
INCOME TAX BENEFIT: -880K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Alkermes, Inc. (NASDAQ: ALKS) reported Q4 EPS of ($0.14), in-line with the analyst estimate of ($0.14). Revenue for the quarter came in at $42.28 million versus the consensus estimate of $46.32 million.
Sees FY12 loss of 38-47c, vs. the consensus of 30c loss. See sales of $205-$229 million, vs. the consensus of $213.7 million.
Sees FY12 loss of 38-47c, vs. the consensus of 30c loss. See sales of $205-$229 million, vs. the consensus of $213.7 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Ross Stores (ROST) Tops Q2 EPS by 72c, Beats on Revenue
- Wolfspeed (WOLF) Misses Q4 EPS by 174c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
